Literature DB >> 19021607

Race affects access to nephrectomy but not survival in renal cell carcinoma.

Laurent Zini1, Paul Perrotte, Umberto Capitanio, Claudio Jeldres, Alain Duclos, Philippe Arjane, Arnauld Villers, Francesco Montorsi, Jean-Jacques Patard, Pierre I Karakiewicz.   

Abstract

OBJECTIVES: To assess whether, in contemporary patients with renal cell carcinoma (RCC), access to nephrectomy is the same between the Blacks and Whites, and that there is no difference in mortality after stratification for treatment type. PATIENTS AND METHODS: The effect of race has received little attention in RCC; only two reports have addressed and suggested the presence of racial disparities, including access to nephrectomy and survival after nephrectomy, where Black patients were disadvantaged relative to Whites. We used the Surveillance, Epidemiology and End Results data from 12 516 patients of all stages diagnosed and treated for RCC between 2000 and 2004. The effect of race (Black vs White) on nephrectomy rate was addressed in logistic regression and binomial regression models, and Cox regression models tested the effect of race on overall survival.
RESULTS: Black patients were 50% less likely to have a nephrectomy than their White counterparts. However, race had no effect on overall survival when the entire cohort was assessed, as well as in subgroups of patients with or without nephrectomy.
CONCLUSIONS: Although race is a determinant of access to nephrectomy, it should not be interpreted as a barrier to care, as survival was unaffected by race in patients having a nephrectomy or not. Instead, race might represent a proxy of comorbidity and life-expectancy, which represent surgical selection criteria for nephrectomy.

Entities:  

Mesh:

Year:  2008        PMID: 19021607     DOI: 10.1111/j.1464-410X.2008.08119.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  10 in total

1.  Renal cancer paradox: higher incidence but not higher mortality among African-Americans.

Authors:  Loren Lipworth; Joseph K McLaughlin; Robert E Tarone; William J Blot
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

2.  Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Authors:  Wong-Ho Chow; Brian Shuch; W Marston Linehan; Susan S Devesa
Journal:  Cancer       Date:  2012-11-12       Impact factor: 6.860

3.  Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma.

Authors:  Christopher S Hollenbeak; Lucas E Nikkel; Eric W Schaefer; Evo Alemao; Nasrollah Ghahramani; Jay D Raman
Journal:  J Manag Care Pharm       Date:  2011-10

4.  Characterizing changes in kidney and renal pelvis cancer incidence from 1998 to 2006 in the United States.

Authors:  Michael Knox; Janet L Colli
Journal:  Int Urol Nephrol       Date:  2010-09-05       Impact factor: 2.370

5.  Survival among Black and White patients with renal cell carcinoma in an equal-access health care system.

Authors:  Jie Lin; Shelia H Zahm; Craig D Shriver; Mark Purdue; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Causes Control       Date:  2015-05-09       Impact factor: 2.506

6.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

7.  Racial Disparities and Preventive Measures to Renal Cell Carcinoma.

Authors:  Jennifer N Sims; Clement G Yedjou; Daniel Abugri; Marinelle Payton; Timothy Turner; Lucio Miele; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2018-05-28       Impact factor: 3.390

8.  Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.

Authors:  Sicong Du; Yu Zhong; Shuai Zheng; Jun Lyu
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

9.  Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans.

Authors:  William B Grant; Alan N Peiris
Journal:  Dermatoendocrinol       Date:  2012-04-01

10.  Racial disparities in renal cell carcinoma: a single-payer healthcare experience.

Authors:  Abiodun Mafolasire; Xiaopan Yao; Cayce Nawaf; Alfredo Suarez-Sarmiento; Wong-Ho Chow; Wei Zhao; Douglas Corley; Jonathan N Hofmann; Mark Purdue; Adebowale J Adeniran; Brian Shuch
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.